Borderline Personality Disorder, National Education Alliance for

Borderline Personality Disorder:
Origins, Treatments, and Family Perspectives

Saturday, May 7, 2005
Mary S. Harkness Auditorium, New Haven, CT

  Sponsored by:
The National Education Alliance for Borderline Personality Disorder (NEA-BPD) in 
partnership with the National Alliance for Research on Schizophrenia and Depression (NARSAD)
   In cooperation with: 
Yale-New Haven Psychiatric Hospital
Department of Psychiatry, Yale University School of Medicine
The National Alliance for the Mentally Ill-Connecticut
  Conference Objectives
At the conclusion of the conference, attendees will be better able to identify, specify, and describe:

1. The symptomatology of BPD
2. The current understanding of emotion dysregulation
3. The complexities of the diagnostic issues surrounding BPD
4. Issues of concern to consumers and family members
5. Research design elements and outcomes of a family program
6. The problems and options of medication programs for people with BPD
7. Three psychosocial treatment modalities
  Course Description
The Conference is for physicians, psychiatrists, psychologists, social workers, family therapists, counselors, nurses, emergency room personnel, law enforcement personnel and agencies, family members, consumers, and educators.
Continuing Education credits for social workers and Certificates of Attendance are also available upon request. 
  Statement of Need
Borderline Personality Disorder (BPD) is a severe and generally chronic disorder and people who suffer from it are underserved. Friends and families are often bewildered and do not know how to help. Treatment programs for those with BPD need to be more readily available. Families need access to programs such as those already developed for several other mental illnesses. BPD presents patients, their families and researchers with multiple challenges. These complex challenges will be addressed in order to inform mental health professionals, families, and consumers of the most current diagnostic and treatment options available, and other issues of current interest to those affected by the disorder. 

  Conference Program  
  Moderator for the day: Seth R. Axelrod, PhD  
  Welcome Perry D. Hoffman, PhD
The Mount Sinai School of Medicine
President, NEA-BPD
Seth R. Axelrod, PhD
Assistant Professor of Psychiatry
Intensive Outpatient Program DBT/DBT-S Team Leader
Yale-New Haven Psychiatric Hospital
Yale University School of Medicine
  Opening Remarks
Benjamin S. Bunney, MD
Charles B.G. Murphy Professor and Chairman of Psychiatry
Professor of Pharmacology
Yale University School of Medicine
  Borderline Personality Disorder: What Is It? Robert Stern, MD, PhD
Associate Clinical Professor of Psychiatry
Yale University School of Medicine 
  Biopsychology of Emotion Dysregulation Rajita Sinha, PhD
Associate Professor of Psychiatry
Director, Research Program on Stress, Addiction and Psychopathology 
Director, Addiction Services
Connecticut Mental Health Center 
Yale University School of Medicine
  Disclosing the BPD Diagnosis: Practice and Recommendations
Richard G. Hersh, MD
Assistant Clinical Professor of Psychiatry 
Columbia University College of Physicians and Surgeons 
Assistant Director of the Intensive Outpatient Program 
Columbia Presbyterian Medical Center
  Family and Consumer Perspectives Panel, and Family Research Dixianne Penney, Dr.PH
Executive Vice-President, NEA-BPD
Administrative Director
Center for the Study of Issues in Public Health
Nathan Kline Institute for Psychiatric Research
Perry D. Hoffman, PhD

Ellie Buteau, PhD
  Psychopharmacology of BPD: Benefits and Limitations Kenneth R. Silk, MD
Professor and Associate Chair
Clinical and Administrative Affairs
Department of Psychiatry
University of Michigan Health System
  Transference-Focused Psychotherapy
Frank E.Yeomans, MD, PhD
Director of Training
Personality Disorders Institute
Clinical Associate Professor of Psychiatry
Weill School of Medicine at Cornell University
  Dialectical Behavior Therapy George H. Davis, PhD
Clinical Director
Center for Dialectical and Cognitive Behavioral Therapies
Assistant Clinical Professor of Psychiatry
Yale University School of Medicine
  Schema-Focused Therapy Samuel A. Ball, PhD
Associate Professor of Psychiatry 
Director of Training, NIDA Clinical Trials Network (New England Node)
Director of Residential Services, APT Foundation
Yale University School of Medicine
Veterans Administration Connecticut Healthcare
  Treatment Panel: Question and Answer Time


Site by AMS Web Services